Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totalling 816,800 shares, an increase of 830.3% from the September 15th total of 87,800 shares. Based on an average daily trading volume, of 2,820,000 shares, the short-interest ratio is currently 0.3 days.
SNOA stock opened at $5.86 on Thursday. The company has a market cap of $12.26 million, a P/E ratio of -2.31 and a beta of 0.77. The company’s 50-day moving average price is $5.76 and its 200 day moving average price is $6.91. Sonoma Pharmaceuticals has a 52 week low of $5.15 and a 52 week high of $15.19.
Sonoma Pharmaceuticals (NASDAQ:SNOA) last announced its earnings results on Monday, August 16th. The company reported ($0.52) earnings per share (EPS) for the quarter. The business had revenue of $3.68 million for the quarter. Sonoma Pharmaceuticals had a negative return on equity of 59.12% and a negative net margin of 31.96%.
About Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc engages in developing and producing Stabilized Hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. Its products educe infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner.
Receive News & Ratings for Sonoma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonoma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.